Union Bancaire Privee UBP SA decreased its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 21.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 214,004 shares of the company's stock after selling 59,701 shares during the quarter. Union Bancaire Privee UBP SA's holdings in Procter & Gamble were worth $34,095,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also added to or reduced their stakes in PG. Kingstone Capital Partners Texas LLC lifted its position in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC purchased a new position in Procter & Gamble during the first quarter valued at $1,954,941,000. Price T Rowe Associates Inc. MD lifted its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after buying an additional 2,466,308 shares during the period. Invesco Ltd. lifted its position in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after buying an additional 2,228,151 shares during the period. Finally, Assenagon Asset Management S.A. lifted its position in Procter & Gamble by 140.4% during the first quarter. Assenagon Asset Management S.A. now owns 2,663,246 shares of the company's stock valued at $453,870,000 after buying an additional 1,555,504 shares during the period. Hedge funds and other institutional investors own 65.77% of the company's stock.
Wall Street Analysts Forecast Growth
PG has been the subject of several recent research reports. BNP Paribas Exane lowered their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research report on Tuesday, September 23rd. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. UBS Group set a $180.00 price target on Procter & Gamble and gave the stock a "buy" rating in a research report on Wednesday, July 30th. BNP Paribas reaffirmed an "outperform" rating and issued a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Finally, Berenberg Bank lifted their price target on Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a research report on Wednesday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $173.68.
Check Out Our Latest Stock Analysis on Procter & Gamble
Insiders Place Their Bets
In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of the business's stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares of the company's stock, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Marc S. Pritchard sold 9,849 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the transaction, the insider directly owned 182,422 shares of the company's stock, valued at approximately $28,689,507.94. This trade represents a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock worth $18,918,012 in the last quarter. Insiders own 0.20% of the company's stock.
Procter & Gamble Price Performance
Shares of NYSE:PG opened at $153.67 on Wednesday. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The business has a 50-day simple moving average of $155.87 and a two-hundred day simple moving average of $160.34. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The firm has a market cap of $359.66 billion, a price-to-earnings ratio of 23.61, a price-to-earnings-growth ratio of 4.05 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the previous year, the firm earned $1.40 EPS. Procter & Gamble's revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a $1.0568 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.8%. Procter & Gamble's payout ratio is 64.98%.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report